SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-23-000670
Filing Date
2023-05-02
Accepted
2023-05-02 06:34:30
Documents
13
Period of Report
2023-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 IDEXX LABORATORIES, INC. 8-K a53391037.htm   iXBRL 8-K 31429
2 EXHIBIT 99.1 a53391037ex99_1.htm EX-99.1 652423
  Complete submission text file 0001157523-23-000670.txt   857704

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20230502.xsd EX-101.SCH 3856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20230502_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20230502_pre.xml EX-101.PRE 16038
7 EXTRACTED XBRL INSTANCE DOCUMENT a53391037_htm.xml XML 4063
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

IRS No.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 23876548
SIC: 2835 In Vitro & In Vivo Diagnostic Substances